About this trial
Duke University will serve as the clinical research site for the Phase II RCT of the VALOR system, which enables telehealth delivery of evidence-based upper extremity (UE) stroke therapy in a patient's home using immersive VR headset technology for guided practice of activities of daily living (ADLs) and instrumental ADLs (IADLs). The study compares VALOR Home Exercise Program (HEP) to Usual Care Treatment (UCT) in adults with stroke-related UE impairment.
Eligibility criteria
Qualifiers
Participant has had a right or left hemispheric stroke affecting normal hand function.
At least 3 months have passed since the last stroke.
Participant has sufficient active finger flexion at the MCP joint in at least one finger to be detected by visual observation by a study therapist.
Participant has visual acuity with corrective lenses of 20/50 or better.
Disqualifiers
None
Trial design
Treatments tested in this trial
- VALOR Home Exercise Program (HEP)
- Usual Care Treatment (UCT) Control
Treatment groups
Sponsors and collaborators
Barron Associates, Inc.
Lead sponsor
Duke University
Collaborator